NCT04935970

Brief Summary

The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D, homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and central origin (vestibular migraine). Also we will analyse another factors (such as anxiety and depression) and optimize therapeuthical approach accordingly with the data.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2019

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 11, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 23, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
Last Updated

June 23, 2021

Status Verified

March 1, 2021

Enrollment Period

2.1 years

First QC Date

April 11, 2021

Last Update Submit

June 15, 2021

Conditions

Keywords

Benign paroxysmal positional vertigo (BPPV)vestibular neuritisvestibular migrainecentral positional vertigoMeniere diseasepersistent postural-perceptual dizziness (PPPD)vitamin D deficiencyhyperhomocysteinaemia

Outcome Measures

Primary Outcomes (2)

  • vitamin D deficiency/insufficiency reveal

    enzyme-linked immunosorbent assay (ELISA).

    Through 1-6 months of diagnosis established.

  • hyperhomocysteinaemia reveal

    enzyme-linked immunosorbent assay (ELISA).

    Through 1-6 months of diagnosis established.

Secondary Outcomes (1)

  • correlation between metabolic and neuropsychological disorders

    through study completion, an average of 1 year

Study Arms (3)

patients with peripherial vestibular disorder

Forty patients with BPPV, vestibular neuritis or another peripherial vestibular disorder

Diagnostic Test: diagnostic blood testDiagnostic Test: neuropsychological test

patients with central vestibular disorder

Forty patients vestibular disorder of central origin

Diagnostic Test: diagnostic blood testDiagnostic Test: neuropsychological test

healthy controls

twenty healthy control without balance problems

Diagnostic Test: diagnostic blood test

Interventions

diagnostic blood testDIAGNOSTIC_TEST

vitamin D deficiency/insufficiency reveal, hyperhomocysteinaemia reveal

healthy controlspatients with central vestibular disorderpatients with peripherial vestibular disorder

neuropsychological test, including tas-26 scale, Beck's Depression Inventory, Spielberg-Hanin'scale.

patients with central vestibular disorderpatients with peripherial vestibular disorder

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients from clinic with damage of peripheral and central origin

You may qualify if:

  • Written informed consent of participation in the study;
  • Age:over 18 years old
  • complaints of dizziness and insteadiness

You may not qualify if:

  • Severe cognitive impairment (dementia)
  • Severe depression
  • Syncopal paroxysms
  • Epileptic seizures
  • Orthostatic hypotension
  • Severe arrhythmia, unstable angina pectoris, acute myocardial infarction
  • Pregnancy 8. Alcoholism, substance abuse and drug addiction
  • Organic liver and kidney diseases with the development of functional disorders.
  • Anemia (hemoglobin \<10.5 g / dl for women and \<11.5 g / dl for men)
  • Active oncological process
  • Demyelinating and neurodegenerative diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic of Neurology and Neurosurgery of I.M. Sechenov First Moscow State Medical University (Sechenov University)

Moscow, Russia

RECRUITING

Related Publications (4)

  • Bedenko A.S., Antonenko L.М., Barinov A.N. Metabolic disorders in the pathogenesis of various causes of dizziness and instability // Annals of the Russian academy of medical sciences. - 2020. - Vol. 75. - N. 6. - P. 605-608. doi: 10.15690/vramn1244

    BACKGROUND
  • Bedenko A.S. Vertigo in neurological practice: rare causes and difficult decisions. Medical alphabet. 2019;2(19):34-36. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-19(394)-34-36

    BACKGROUND
  • Bedenko A.S. Metabolic factors in pathogenesis of migraine and unsteadiness. Medical alphabet. 2020;(33):18-20. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-18-20

    BACKGROUND
  • Bedenko A.S. Vertigo caused by vestibular migraine: current problems of pathogenesis, diagnostics and therapy. Epilepsy and paroxysmal conditions. 2020;12(3):177-181. (In Russ.)https://doi.org/10.17749/2077-8333/epi.par.con.2020.032

    RESULT

MeSH Terms

Conditions

Benign Paroxysmal Positional VertigoVestibular NeuronitisMeniere DiseaseVitamin D DeficiencyHyperhomocysteinemia

Condition Hierarchy (Ancestors)

VertigoVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsVestibulocochlear Nerve DiseasesRetrocochlear DiseasesCranial Nerve DiseasesEndolymphatic HydropsAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic DiseasesAmino Acid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMalabsorption SyndromesMetabolic DiseasesVitamin B Deficiency

Study Officials

  • Anna Bedenko, PhD student

    I.M. Sechenov First Moscow State Medical University (Sechenov University)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ludmila Antonenko, professor

CONTACT

Anna Bedenko, PhD student

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2021

First Posted

June 23, 2021

Study Start

December 10, 2019

Primary Completion

December 30, 2021

Study Completion

August 31, 2022

Last Updated

June 23, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

I give my consent to provide actual study protocol. However, It is impossible to provide stastistical documents and primary patient's documentation (It is forbidden by Local Ethic Committee of Sechenov University)

Locations